• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒感染的流行病学、传播、诊断及转归

Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.

作者信息

Moosavy Seyed Hamid, Davoodian Parivash, Nazarnezhad Mirza Ali, Nejatizaheh Abdolazim, Eftekhar Ebrahim, Mahboobi Hamidreza

机构信息

M.D., Gastroenterologist and Hepatologist, Associate Professor, Department of Internal Medicine, Infectious and Tropical Disease Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran.

M.D., Infectionist, Associate Professor, Infectious and Tropical Disease Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran.

出版信息

Electron Physician. 2017 Oct 25;9(10):5646-5656. doi: 10.19082/5646. eCollection 2017 Oct.

DOI:10.19082/5646
PMID:29238510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5718874/
Abstract

Hepatitis C infection is one of the main causes of chronic liver disorders worldwide. Nearly three percent (3%) of the world population has an HCV infection. Prevalence of HCV infection was higher in some groups such as injected drug users (IDUs) and HIV positive populations. Acute hepatitis has proven asymptomatic in most cases, and delay of diagnosis might lead to late onset of hepatocellular carcinoma and cirrhosis. Some host characteristics such as age, gender, body mass index, and viral properties are associated with HCV outcome hepatitis. Although disease progression is typically slow, some risk factors such as alcohol abuse and coinfection of patients with HBV and HIV can worsen the disease. On the other hand, viral overload is one of the main causes of prediction of HCV infection outcome. Prevalence of HCV infection will increase if we do not consider means of transmission, virus behaviors, and immunologic responses. Rapid diagnostic tests can help us to create preventive strategies among undeveloped villages and prisoners. Screening and training of the high-risk population such as IV drug users, dialysis patients, and hemophiliacs must be one of main HCV preventive programs. The present review is intended to help health policymakers to design suitable preventive and management programs.

摘要

丙型肝炎感染是全球慢性肝脏疾病的主要病因之一。全球近3%的人口感染了丙肝病毒(HCV)。在一些群体中,如注射吸毒者(IDU)和艾滋病毒阳性人群,HCV感染的患病率更高。在大多数情况下,急性肝炎已被证明是无症状的,诊断延迟可能导致肝细胞癌和肝硬化的晚期发病。一些宿主特征,如年龄、性别、体重指数和病毒特性与丙型肝炎的预后有关。虽然疾病进展通常缓慢,但一些危险因素,如酗酒以及患者同时感染乙肝病毒和艾滋病毒,会使病情恶化。另一方面,病毒载量是预测HCV感染结果的主要原因之一。如果我们不考虑传播途径、病毒行为和免疫反应,HCV感染的患病率将会增加。快速诊断测试可以帮助我们在不发达的村庄和囚犯中制定预防策略。对高危人群,如静脉吸毒者、透析患者和血友病患者进行筛查和培训,必须是主要的丙肝预防项目之一。本综述旨在帮助卫生政策制定者设计合适的预防和管理项目。

相似文献

1
Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.丙型肝炎病毒感染的流行病学、传播、诊断及转归
Electron Physician. 2017 Oct 25;9(10):5646-5656. doi: 10.19082/5646. eCollection 2017 Oct.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.血吸虫物种与乙型肝炎或丙型肝炎病毒的合并感染。
Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5.
4
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.附录:美国国立卫生研究院2002年丙型肝炎共识发展会议管理办法
Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8.
5
Viral hepatitis and HIV infection among injection drug users in a central Iranian City.伊朗中部城市注射吸毒者中的病毒性肝炎和 HIV 感染。
J Addict Med. 2012 Dec;6(4):292-6. doi: 10.1097/ADM.0b013e3182659928.
6
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.预测英国注射相关丙型肝炎病毒流行的严重后遗症。第1部分:重症丙型肝炎和注射者数据。
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
7
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.分散式与集中式药物替代方案中丙型肝炎的管理以及用于弥合丙型肝炎病毒治疗流程差距的微创即时检测
Swiss Med Wkly. 2017 Nov 20;147:w14544. doi: 10.4414/smw.2017.14544. eCollection 2017.
8
The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.丙型肝炎治疗和人类免疫缺陷病毒(HIV)合并感染对阿姆斯特丹注射吸毒者丙型肝炎疾病负担的影响。
Addiction. 2012 Mar;107(3):614-23. doi: 10.1111/j.1360-0443.2011.03654.x.
9
Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.与西班牙大加那利岛注射吸毒者相比,非注射吸毒者中乙肝病毒、丁型肝炎病毒、丙型肝炎病毒和艾滋病毒血清学标志物的流行情况。
Eur J Epidemiol. 1998 Sep;14(6):555-61. doi: 10.1023/a:1007410707801.
10
Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.伊朗霍拉桑省比尔詹德地区男性吸毒囚犯中乙型和丙型肝炎的流行情况
Arch Iran Med. 2019 Sep 1;22(9):501-504.

引用本文的文献

1
Assessing user experience with the Bioline™ HCV point-of-care test in primary healthcare settings: a mixed-methods study.在基层医疗环境中评估用户对Bioline™丙型肝炎即时检测的体验:一项混合方法研究。
BMC Health Serv Res. 2025 Apr 1;25(1):484. doi: 10.1186/s12913-025-12634-8.
2
REASSURED evaluation of the Bioline HCV point-of-care testing for diagnosing hepatitis C virus infection in primary healthcare settings of Ghana: a study protocol.加纳基层医疗保健环境中用于诊断丙型肝炎病毒感染的 Bioline HCV 即时检测的放心评估:研究方案。
BMJ Open. 2024 Nov 9;14(11):e082416. doi: 10.1136/bmjopen-2023-082416.
3
Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study.直接作用抗病毒药物(DAA)疗法对肝肾移植后复发性丙型肝炎患者的疗效:一项横断面研究。
Front Med (Lausanne). 2024 Oct 9;11:1460372. doi: 10.3389/fmed.2024.1460372. eCollection 2024.
4
Cellular Transformation by Human Cytomegalovirus.人巨细胞病毒引起的细胞转化
Cancers (Basel). 2024 May 22;16(11):1970. doi: 10.3390/cancers16111970.
5
Advanced Theranostic Strategies for Viral Hepatitis Using Carbon Nanostructures.使用碳纳米结构的病毒性肝炎先进诊疗策略
Micromachines (Basel). 2023 Jun 1;14(6):1185. doi: 10.3390/mi14061185.
6
Inhibitory effects of Ganoderma lucidum triterpenoid on the growth and metastasis of hepatocellular carcinoma.灵芝三萜对肝癌生长和转移的抑制作用。
Am J Transl Res. 2023 May 15;15(5):3410-3423. eCollection 2023.
7
Knowledge of and Testing Rate for Hepatitis C Infection among the General Public of Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯普通公众对丙型肝炎感染的认知和检测率:一项横断面研究。
Int J Environ Res Public Health. 2023 Jan 23;20(3):2080. doi: 10.3390/ijerph20032080.
8
High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence.明尼苏达州索马里人慢性乙型和丙型病毒性肝炎的高流行率导致肝细胞癌发病率上升。
World J Gastroenterol. 2022 Sep 21;28(35):5217-5229. doi: 10.3748/wjg.v28.i35.5217.
9
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.利用作为候选疫苗的分泌型丙型肝炎病毒 E1E2 异二聚体诱导广谱中和抗体。
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2112008119. doi: 10.1073/pnas.2112008119. Epub 2022 Mar 9.
10
Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.丙型肝炎病毒相关的中枢和周围神经系统疾病
Brain Sci. 2021 Nov 27;11(12):1569. doi: 10.3390/brainsci11121569.

本文引用的文献

1
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.丙型肝炎指南:美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染成人检测、管理及治疗的建议
Hepatology. 2015 Sep;62(3):932-54. doi: 10.1002/hep.27950. Epub 2015 Aug 4.
2
Global epidemiology and genotype distribution of the hepatitis C virus infection.全球丙型肝炎病毒感染的流行病学和基因型分布。
J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.
3
Global distribution and prevalence of hepatitis C virus genotypes.丙型肝炎病毒基因型的全球分布与流行情况
Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. Epub 2014 Jul 28.
4
Vertical transmission of hepatitis C virus: systematic review and meta-analysis.丙型肝炎病毒的垂直传播:系统评价与荟萃分析。
Clin Infect Dis. 2014 Sep 15;59(6):765-73. doi: 10.1093/cid/ciu447. Epub 2014 Jun 13.
5
Current management of hepatocellular carcinoma.肝细胞癌的当前管理
Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61.
6
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.肝细胞癌综述:当前的治疗方法与循证医学
World J Gastroenterol. 2014 Apr 21;20(15):4115-27. doi: 10.3748/wjg.v20.i15.4115.
7
Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.外周血单个核细胞 microRNA 预测丙型肝炎病毒基因型 1 感染的治疗效果。
Antiviral Res. 2014 May;105:135-42. doi: 10.1016/j.antiviral.2014.03.003. Epub 2014 Mar 15.
8
Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran.伊朗霍尔木兹甘省丙型肝炎病毒感染患者中丙型肝炎病毒基因型的分布
Hepat Mon. 2013 Dec 16;13(12):e14324. doi: 10.5812/hepatmon.14324. eCollection 2013.
9
Frequency of HCV infection in different dermatological disorders.
J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):58-61.
10
Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011).伊朗北部阿莫勒市丙型肝炎病毒感染的患病率及危险因素:一项基于人群的研究(2008 - 2011年)
Hepat Mon. 2013 Dec 7;13(12):e13313. doi: 10.5812/hepatmon.13313. eCollection 2013.